S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
Log in
OTCMKTS:SSMXY

Sysmex Stock Forecast, Price & News

$62.71
-0.52 (-0.82 %)
(As of 01/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$62.16
Now: $62.71
$62.84
50-Day Range
$53.65
MA: $58.96
$63.95
52-Week Range
$26.29
Now: $62.71
$65.49
Volume24,886 shs
Average Volume20,353 shs
Market Capitalization$26.18 billion
P/E Ratio95.02
Dividend Yield0.40%
Beta0.24
Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

MarketRank

Overall MarketRank

0.57 out of 5 stars

Medical Sector

1354th out of 1,926 stocks

Private Households Industry

272nd out of 378 stocks

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SSMXY
CUSIPN/A
CIKN/A
Phone817-8265-0500
Employees8,200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.78 billion
Cash Flow$1.32 per share
Book Value$6.13 per share

Profitability

Net Income$320.91 million

Miscellaneous

Market Cap$26.18 billion
Next Earnings Date2/3/2021 (Estimated)
OptionableNot Optionable
$62.71
-0.52 (-0.82 %)
(As of 01/21/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SSMXY News and Ratings via Email

Sign-up to receive the latest news and ratings for SSMXY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sysmex (OTCMKTS:SSMXY) Frequently Asked Questions

How has Sysmex's stock been impacted by COVID-19?

Sysmex's stock was trading at $30.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SSMXY stock has increased by 104.8% and is now trading at $62.71.
View which stocks have been most impacted by COVID-19
.

Is Sysmex a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sysmex in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Sysmex stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SSMXY, but not buy additional shares or sell existing shares.
View analyst ratings for Sysmex
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Sysmex?

Wall Street analysts have given Sysmex a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sysmex wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Sysmex's next earnings date?

Sysmex is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Sysmex
.

How were Sysmex's earnings last quarter?

Sysmex Co. (OTCMKTS:SSMXY) issued its earnings results on Thursday, November, 5th. The company reported $0.18 earnings per share for the quarter. The firm earned $674.41 million during the quarter. Sysmex had a net margin of 10.29% and a return on equity of 10.73%.
View Sysmex's earnings history
.

Is Sysmex a good dividend stock?

Sysmex pays an annual dividend of $0.25 per share and currently has a dividend yield of 0.40%. The dividend payout ratio of Sysmex is 32.47%. This payout ratio is at a healthy, sustainable level, below 75%.
View Sysmex's dividend history.

What guidance has Sysmex issued on next quarter's earnings?

Sysmex updated its FY 2021 Pre-Market earnings guidance on Thursday, November, 5th. The company provided EPS guidance of 1.39-1.39 for the period. The company issued revenue guidance of $2.914-2.914 billion.

Are investors shorting Sysmex?

Sysmex saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 7,900 shares, a decline of 44.0% from the December 15th total of 14,100 shares. Based on an average daily volume of 44,900 shares, the short-interest ratio is presently 0.2 days.
View Sysmex's Short Interest
.

Who are some of Sysmex's key competitors?

Who are Sysmex's key executives?

Sysmex's management team includes the following people:
  • Mr. Hisashi Ietsugu, Chairman of the Managing Board & CEO (Age 72)
  • Mr. Yukio Nakajima, Sr. Exec. Officer, Sr. MD of Corp. Bus. Planning & Admin., CFO & Member of Managing Board (Age 71)
  • Mr. Kaoru Asano, CTO, COO LS Bus. Unit, Sr. MD, Sr. Exec. Officer & Member of the Managing Board (Age 63)
  • Tomoo Aramaki, Exec. VP of Corp. Bus. Admin.
  • Mr. Yukio Hamaguchi, Sr. Exec. Officer & Exec. VP of Reagent Production
  • Mr. Junzo Yamamoto, Sr. Exec. Officer, MD of Manufacturing & SCM and Member of the Managing Board (Age 66)
  • Mr. Iwane Matsui, Sr. Exec. Officer, MD of Global Bus. & Member of the Managing Board (Age 60)
  • Mr. Kenji Tachibana, Sr. Exec. Officer, Sr. MD, COO IVD Bus. Unit & Member of the Managing Board (Age 64)
  • Mr. Ikuo Otani, Sr. Exec. Officer of IVD Bus. Unit & IVD Product Devel.
  • Mr. Hiroshi Kanda, Sr. Exec. Officer, MD of IVD Bus. Unit & IVD Bus. Devel. & Member of Managing Board (Age 64)

What is Sysmex's stock symbol?

Sysmex trades on the OTCMKTS under the ticker symbol "SSMXY."

How do I buy shares of Sysmex?

Shares of SSMXY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sysmex's stock price today?

One share of SSMXY stock can currently be purchased for approximately $62.71.

How big of a company is Sysmex?

Sysmex has a market capitalization of $26.18 billion and generates $2.78 billion in revenue each year. The company earns $320.91 million in net income (profit) each year or $0.77 on an earnings per share basis. Sysmex employs 8,200 workers across the globe.

What is Sysmex's official website?

The official website for Sysmex is www.sysmex.co.jp.

How can I contact Sysmex?

Sysmex's mailing address is 1-5-1 Wakinohama-Kaigandori Chuo-ku, Kobe M0, 651-0073. The company can be reached via phone at 817-8265-0500.

This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.